Skip to product information
1 of 2

(Box) OSOM Trichomonas vaginalis Test Kit CLIA Waived 25 Tests/Box

(Box) OSOM Trichomonas vaginalis Test Kit CLIA Waived 25 Tests/Box

SKU:BB-SE181

Login view prices
Shipping calculated at checkout.
Default Title
Default Title
View full details

The OSOM Trichomonas Vaginalis Test Kit is a rapid, point‑of‑care diagnostic tool designed for the qualitative detection of Trichomonas vaginalis antigens directly from vaginal swab specimens. It offers a simple, fast, and reliable alternative to traditional lab methods like wet mount microscopy or culture, delivering results in just about 10 minutes without the need for complex equipment or extensive training.

This CLIA‑waived test is particularly well‑suited for physician offices, urgent care centers, women’s health clinics, family planning facilities, OB/GYN practices, and other point‑of‑care settings that require quick and actionable vaginal infection screening.

Key Features and Benefits:

  • Rapid, On‑Site Results: Provides clear results in approximately 10 minutes, supporting immediate clinical decisions during the same patient visit.

  • CLIA‑Waived Simplicity: Designed for low‑complexity use with minimal hands‑on time and no sophisticated laboratory equipment, making it ideal for busy clinical environments.

  • Accurate Antigen Detection: Detects T. vaginalis antigens with high agreement to traditional reference methods (culture and wet mount), improving diagnostic confidence over microscopy alone.

  • Easy Interpretation: Objective, two‑color visual readout eliminates guesswork — a visible test line alongside a control line indicates a positive result.

  • Convenient Packaging: Each box contains 25 individual tests, including swabs and all necessary components for point‑of‑care use.

  • Room Temperature Storage: Stable at standard clinic storage conditions (approx. 15–30 °C) without refrigeration.

Clinical Value:
Trichomoniasis, caused by Trichomonas vaginalis, is one of the most common curable sexually transmitted infections. Fast and accurate detection at the point of care allows healthcare providers to initiate treatment sooner, reduce the spread of infection, and improve patient outcomes — all during the same visit.

This test minimizes reliance on slower or more labor‑intensive methods while bringing actionable diagnostic capability directly into the clinical workflow.